• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰蛋白酶样蛋白酶及其在黏液阻塞性肺疾病中的作用。

Trypsin-Like Proteases and Their Role in Muco-Obstructive Lung Diseases.

机构信息

School of Pharmacy, Queen's University, Belfast BT9 7BL, UK.

Institute for Biomedical and Environmental Health Research, School of Health and Life Sciences, University of the West of Scotland, Paisley PA1 2BE, UK.

出版信息

Int J Mol Sci. 2021 May 29;22(11):5817. doi: 10.3390/ijms22115817.

DOI:10.3390/ijms22115817
PMID:34072295
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8199346/
Abstract

Trypsin-like proteases (TLPs) belong to a family of serine enzymes with primary substrate specificities for the basic residues, lysine and arginine, in the P1 position. Whilst initially perceived as soluble enzymes that are extracellularly secreted, a number of novel TLPs that are anchored in the cell membrane have since been discovered. Muco-obstructive lung diseases (MucOLDs) are characterised by the accumulation of hyper-concentrated mucus in the small airways, leading to persistent inflammation, infection and dysregulated protease activity. Although neutrophilic serine proteases, particularly neutrophil elastase, have been implicated in the propagation of inflammation and local tissue destruction, it is likely that the serine TLPs also contribute to various disease-relevant processes given the roles that a number of these enzymes play in the activation of both the epithelial sodium channel (ENaC) and protease-activated receptor 2 (PAR2). More recently, significant attention has focused on the activation of viruses such as SARS-CoV-2 by host TLPs. The purpose of this review was to highlight key TLPs linked to the activation of ENaC and PAR2 and their association with airway dehydration and inflammatory signalling pathways, respectively. The role of TLPs in viral infectivity will also be discussed in the context of the inhibition of TLP activities and the potential of these proteases as therapeutic targets.

摘要

胰凝乳蛋白酶样蛋白酶(TLPs)属于丝氨酸酶家族,其主要底物特异性为 P1 位的碱性残基赖氨酸和精氨酸。虽然最初被认为是在细胞外分泌的可溶性酶,但后来发现了一些新的锚定在细胞膜上的 TLPs。黏液阻塞性肺病(MucOLDs)的特征是小气道中高浓度黏液的积聚,导致持续的炎症、感染和蛋白酶活性失调。尽管中性粒细胞丝氨酸蛋白酶,特别是中性粒细胞弹性蛋白酶,与炎症的传播和局部组织破坏有关,但鉴于许多这些酶在激活上皮钠离子通道(ENaC)和蛋白酶激活受体 2(PAR2)方面发挥的作用,TLPs 也可能参与各种与疾病相关的过程。最近,人们对宿主 TLPs 激活 SARS-CoV-2 等病毒的作用给予了极大的关注。本综述的目的是强调与 ENaC 和 PAR2 激活相关的关键 TLPs,以及它们分别与气道脱水和炎症信号通路的关联。还将在抑制 TLPs 活性和这些蛋白酶作为治疗靶点的潜力的背景下讨论 TLPs 在病毒感染性方面的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19af/8199346/746d05eff22d/ijms-22-05817-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19af/8199346/018016870be4/ijms-22-05817-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19af/8199346/4a921f50f145/ijms-22-05817-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19af/8199346/bdf1189aa169/ijms-22-05817-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19af/8199346/d47e762f7cd9/ijms-22-05817-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19af/8199346/725de51ef894/ijms-22-05817-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19af/8199346/746d05eff22d/ijms-22-05817-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19af/8199346/018016870be4/ijms-22-05817-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19af/8199346/4a921f50f145/ijms-22-05817-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19af/8199346/bdf1189aa169/ijms-22-05817-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19af/8199346/d47e762f7cd9/ijms-22-05817-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19af/8199346/725de51ef894/ijms-22-05817-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19af/8199346/746d05eff22d/ijms-22-05817-g006.jpg

相似文献

1
Trypsin-Like Proteases and Their Role in Muco-Obstructive Lung Diseases.胰蛋白酶样蛋白酶及其在黏液阻塞性肺疾病中的作用。
Int J Mol Sci. 2021 May 29;22(11):5817. doi: 10.3390/ijms22115817.
2
Serine proteases and protease-activated receptor 2 mediate the proinflammatory and algesic actions of diverse stimulants.丝氨酸蛋白酶和蛋白酶激活受体2介导多种刺激物的促炎和致痛作用。
Br J Pharmacol. 2014 Aug;171(16):3814-26. doi: 10.1111/bph.12738.
3
Proteolytic activation of the epithelial sodium channel (ENaC) by the cysteine protease cathepsin-S.半胱氨酸蛋白酶 cathepsin-S 对上皮钠离子通道(ENaC)的蛋白水解激活作用。
Pflugers Arch. 2012 Oct;464(4):353-65. doi: 10.1007/s00424-012-1138-3. Epub 2012 Aug 5.
4
A substrate for a cell free in vitro assay system to screen drugs targeting trypsin like protease-based cleavage of SARS-CoV-2 spike glycoprotein and viral entry.用于筛选针对 SARS-CoV-2 刺突糖蛋白基于胰蛋白酶样蛋白酶切割和病毒进入的药物的无细胞体外测定系统的底物。
J Med Virol. 2023 May;95(5):e28796. doi: 10.1002/jmv.28796.
5
Proteolytic activation of the human epithelial sodium channel by trypsin IV and trypsin I involves distinct cleavage sites.胰蛋白酶IV和胰蛋白酶I对人上皮钠通道的蛋白水解激活涉及不同的切割位点。
J Biol Chem. 2014 Jul 4;289(27):19067-78. doi: 10.1074/jbc.M113.538470. Epub 2014 May 19.
6
Cleavage in the {gamma}-subunit of the epithelial sodium channel (ENaC) plays an important role in the proteolytic activation of near-silent channels.上皮钠通道(ENaC)γ亚基的裂解在近乎沉默的通道的蛋白水解激活中起重要作用。
J Physiol. 2008 Oct 1;586(19):4587-608. doi: 10.1113/jphysiol.2008.154435. Epub 2008 Jul 31.
7
Sputum trypsin-like protease activity relates to clinical outcome in cystic fibrosis.痰液胰蛋白酶样蛋白酶活性与囊性纤维化的临床结局相关。
J Cyst Fibros. 2020 Jul;19(4):647-653. doi: 10.1016/j.jcf.2019.12.014. Epub 2020 Jan 11.
8
SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.SARS-CoV-2 策略性地模拟人类 ENaC 的蛋白水解激活。
Elife. 2020 May 26;9:e58603. doi: 10.7554/eLife.58603.
9
Protease-activated receptor-2 (PAR2) in the airways.气道中的蛋白酶激活受体-2(PAR2)。
Pulm Pharmacol Ther. 2001;14(3):183-91. doi: 10.1006/pupt.2001.0285.
10
Neutrophil elastase activates near-silent epithelial Na+ channels and increases airway epithelial Na+ transport.中性粒细胞弹性蛋白酶激活近乎沉默的上皮钠通道并增加气道上皮钠转运。
Am J Physiol Lung Cell Mol Physiol. 2005 May;288(5):L813-9. doi: 10.1152/ajplung.00435.2004. Epub 2005 Jan 7.

引用本文的文献

1
Profiling endogenous airway proteases and antiproteases and modeling proteolytic activation of Influenza HA using in vitro and ex vivo human airway surface liquid samples.使用体外和离体人呼吸道表面液体样本分析内源性气道蛋白酶和抗蛋白酶,并模拟流感血凝素的蛋白水解激活。
PLoS One. 2024 Dec 31;19(12):e0306197. doi: 10.1371/journal.pone.0306197. eCollection 2024.
2
Aprotinin (I): Understanding the Role of Host Proteases in COVID-19 and the Importance of Pharmacologically Regulating Their Function.抑肽酶(I):了解宿主蛋白酶在 COVID-19 中的作用及药理调节其功能的重要性。
Int J Mol Sci. 2024 Jul 10;25(14):7553. doi: 10.3390/ijms25147553.
3

本文引用的文献

1
Quest for a COVID-19 Cure by Repurposing Small-Molecule Drugs: Mechanism of Action, Clinical Development, Synthesis at Scale, and Outlook for Supply.通过小分子药物重新利用寻找新冠病毒治疗方法:作用机制、临床开发、大规模合成及供应前景
Org Process Res Dev. 2020 Jun 2;24(6):940-976. doi: 10.1021/acs.oprd.0c00233. eCollection 2020 Jun 19.
2
Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2.α1抗胰蛋白酶是严重急性呼吸综合征冠状病毒2引发蛋白酶TMPRSS2的一种抑制剂。
Pathog Immun. 2021 Apr 26;6(1):55-74. doi: 10.20411/pai.v6i1.408. eCollection 2021.
3
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity.
Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease.
二肽基肽酶 1 抑制作为中性粒细胞介导致炎疾病的一种潜在治疗方法。
Front Immunol. 2023 Dec 14;14:1239151. doi: 10.3389/fimmu.2023.1239151. eCollection 2023.
4
Genotypic Frequencies of Mutations Associated with Alpha-1 Antitrypsin Deficiency in Unrelated Bone Marrow Donors from the Murcia Region Donor Registry in the Southeast of Spain.西班牙东南部穆尔西亚地区供体登记处无关骨髓供体中与α-1抗胰蛋白酶缺乏症相关突变的基因型频率
Diagnostics (Basel). 2023 Sep 2;13(17):2845. doi: 10.3390/diagnostics13172845.
5
Role of epithelial sodium channel-related inflammation in human diseases.上皮钠通道相关炎症在人类疾病中的作用。
Front Immunol. 2023 Jul 25;14:1178410. doi: 10.3389/fimmu.2023.1178410. eCollection 2023.
6
outer membrane vesicles exacerbate retinal microvascular endothelial cell dysfunction in diabetic retinopathy.外膜囊泡会加剧糖尿病视网膜病变中视网膜微血管内皮细胞功能障碍。
Front Microbiol. 2023 May 11;14:1167160. doi: 10.3389/fmicb.2023.1167160. eCollection 2023.
7
Single-cell analysis reveals melanocytes may promote inflammation in chronic wounds through cathepsin G.单细胞分析表明,黑素细胞可能通过组织蛋白酶G促进慢性伤口炎症。
Front Genet. 2023 Jan 23;14:1072995. doi: 10.3389/fgene.2023.1072995. eCollection 2023.
8
Novel Inhibitors and Activity-Based Probes Targeting Trypsin-Like Serine Proteases.靶向类胰蛋白酶丝氨酸蛋白酶的新型抑制剂及基于活性的探针
Front Chem. 2022 Apr 21;10:782608. doi: 10.3389/fchem.2022.782608. eCollection 2022.
9
Trypsin enhances SARS-CoV-2 infection by facilitating viral entry.胰蛋白酶通过促进病毒进入增强了 SARS-CoV-2 的感染。
Arch Virol. 2022 Feb;167(2):441-458. doi: 10.1007/s00705-021-05343-0. Epub 2022 Jan 26.
10
Myeloid Protease-Activated Receptor-2 Contributes to Influenza A Virus Pathology in Mice.髓系蛋白酶激活受体-2 促进小鼠流感病毒病理学。
Front Immunol. 2021 Dec 1;12:791017. doi: 10.3389/fimmu.2021.791017. eCollection 2021.
甲磺酸卡莫司他通过 TMPRSS2 相关蛋白酶抑制 SARS-CoV-2 的激活,其代谢产物 GBPA 发挥抗病毒活性。
EBioMedicine. 2021 Mar;65:103255. doi: 10.1016/j.ebiom.2021.103255. Epub 2021 Mar 4.
4
Aprotinin Inhibits SARS-CoV-2 Replication.抑肽酶抑制 SARS-CoV-2 复制。
Cells. 2020 Oct 30;9(11):2377. doi: 10.3390/cells9112377.
5
Overview of the First 6 Months of Clinical Trials for COVID-19 Pharmacotherapy: The Most Studied Drugs.COVID-19 药物治疗临床试验前 6 个月概述:研究最多的药物。
Front Public Health. 2020 Aug 21;8:497. doi: 10.3389/fpubh.2020.00497. eCollection 2020.
6
Long term respiratory complications of covid-19.新冠病毒病的长期呼吸系统并发症
BMJ. 2020 Aug 3;370:m3001. doi: 10.1136/bmj.m3001.
7
SARS-CoV-2 (COVID-19) and cystic fibrosis.严重急性呼吸综合征冠状病毒 2 型(COVID-19)与囊性纤维化。
Am J Physiol Lung Cell Mol Physiol. 2020 Sep 1;319(3):L408-L415. doi: 10.1152/ajplung.00225.2020. Epub 2020 Jul 15.
8
Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD.儿童气道中严重急性呼吸综合征冠状病毒2(SARS-CoV-2)受体血管紧张素转换酶2(ACE2)和跨膜丝氨酸蛋白酶2(TMPRSS2)的表达低于成人,并随吸烟和慢性阻塞性肺疾病(COPD)而增加。
Mol Ther Methods Clin Dev. 2020 May 22;18:1-6. doi: 10.1016/j.omtm.2020.05.013. eCollection 2020 Sep 11.
9
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19.甲磺酸那法莫司他可阻断新型冠状病毒激活:新冠肺炎的新治疗选择。
Antimicrob Agents Chemother. 2020 May 21;64(6). doi: 10.1128/AAC.00754-20.
10
Transcriptome profiling and protease inhibition experiments identify proteases that activate H3N2 influenza A and influenza B viruses in murine airways.转录组谱分析和蛋白酶抑制实验鉴定了在小鼠气道中激活 H3N2 流感 A 病毒和流感 B 病毒的蛋白酶。
J Biol Chem. 2020 Aug 14;295(33):11388-11407. doi: 10.1074/jbc.RA120.012635. Epub 2020 Apr 17.